Acrivon Therapeutics (ACRV)10% owner sold ~$401K
PERCEPTIVE ADVISORS LLC, 10% owner at Acrivon Therapeutics, sold ~$401K of Acrivon Therapeutics shares.
- ~$401K
- Approx. value · 299K sh @ $1.34
- 3.1M
- Holds after · shares reported
- Traded
- May 1, 2025
- Filed
- May 1, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 25, 2025Insider10% owner sold ~$2.06M of ACRV shares in the open market
- Apr 28, 2025Insider10% owner sold ~$336K of ACRV shares in the open market
- Apr 29, 2025Insider10% owner sold ~$353K of ACRV shares in the open market
- Apr 30, 2025Insider10% owner sold ~$617K of ACRV shares in the open market
- May 1, 2025 · this disclosureInsider10% owner sold ~$401K of ACRV shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Acrivon Therapeutics
OQRO holds no insider, Congress, fund or contract record for Acrivon Therapeutics dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ACRV page.
Other recent filings by PERCEPTIVE ADVISORS LLC, 10% owner
- SEC Form 4 at Orchestra Biomed Holdings (OBIO)Aug 5, 2025
- SEC Form 4 at Acrivon Therapeutics (ACRV)May 1, 2025
- SEC Form 4 at Acrivon Therapeutics (ACRV)Apr 29, 2025
- SEC Form 4 at Acrivon Therapeutics (ACRV)Apr 29, 2025
- SEC Form 4 at Acrivon Therapeutics (ACRV)Apr 29, 2025
The full history of PERCEPTIVE ADVISORS LLC, 10% owner is on the profile page.
How this filing works
Other disclosures at Acrivon Therapeutics
- SEC Form 13F-HRAug 14, 2025
- SEC Form 4May 1, 2025
- SEC Form 4Apr 29, 2025
- SEC Form 4Apr 29, 2025
- SEC Form 4Apr 29, 2025
Everything OQRO holds on this company is on its ACRV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data